Search

everythinglearnresearchcommunity

for

Search:↓

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

COVID-19 can cause significant hair loss.

Scalp pain should be classified as a type of headache.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Covid-19 can cause hair loss due to immune and psychological factors.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

COVID-19 can cause hair loss, but specialists can help treat it.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Older adults in Puerto Rico often couldn't be tested for hair cortisol due to refusal or lack of hair, with race and hair products affecting results.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

COVID-19 can cause different skin issues, including rashes and hair loss.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

COVID-19 can cause various skin issues, including rashes and lesions.

COVID-19 protective measures led to skin irritation, hair loss, and brittle nails; using skin-friendly products and a healthy diet is recommended.

Topical Minoxidil is effective for hair loss after COVID-19.